Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Medicinal Products for Human Use,16-18 October 2006 19 Οκτώβριος 2006Press releaseHuman La Jolla Limited withdraws its marketing authorisation application for Riquent 13 Οκτώβριος 2006Press release Novo Nordisk withdraws its application to extend the marketing authorisations for NovoNorm and Prandin 13 Οκτώβριος 2006Press release Committee for medicinal products for veterinary use: Meeting of 10 to 12 October 2006 12 Οκτώβριος 2006Press releaseVeterinary Committee for medicinal products for veterinary use: Meeting of 4 to 6 October 2005 7 Οκτώβριος 2006Press releaseVeterinary Rise in applications for medicines in 2006, concerns over budget situation for 2007 and new transparency measures 6 Οκτώβριος 2006Press release Committee for Orphan Medicinal Products: October 2006 meeting 4 Οκτώβριος 2006Press releaseHumanRare diseases European Medicines Agency update on review of non-selective NSAIDs 26 Σεπτέμβριος 2006Press releaseMedicines Meeting highlights from the Committee for Medicinal Products for Human Use, 18-21 September 2006 21 Σεπτέμβριος 2006Press releaseHuman Committee for medicinal products for veterinary use: Meeting of 12 to 14 September 2006 14 Σεπτέμβριος 2006Press releaseVeterinary 1 … 329 330 331 332 333 Page 333 of 384 334 335 336 337 … 384
Meeting highlights from the Committee for Medicinal Products for Human Use,16-18 October 2006 19 Οκτώβριος 2006Press releaseHuman
La Jolla Limited withdraws its marketing authorisation application for Riquent 13 Οκτώβριος 2006Press release
Novo Nordisk withdraws its application to extend the marketing authorisations for NovoNorm and Prandin 13 Οκτώβριος 2006Press release
Committee for medicinal products for veterinary use: Meeting of 10 to 12 October 2006 12 Οκτώβριος 2006Press releaseVeterinary
Committee for medicinal products for veterinary use: Meeting of 4 to 6 October 2005 7 Οκτώβριος 2006Press releaseVeterinary
Rise in applications for medicines in 2006, concerns over budget situation for 2007 and new transparency measures 6 Οκτώβριος 2006Press release
Committee for Orphan Medicinal Products: October 2006 meeting 4 Οκτώβριος 2006Press releaseHumanRare diseases
European Medicines Agency update on review of non-selective NSAIDs 26 Σεπτέμβριος 2006Press releaseMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use, 18-21 September 2006 21 Σεπτέμβριος 2006Press releaseHuman
Committee for medicinal products for veterinary use: Meeting of 12 to 14 September 2006 14 Σεπτέμβριος 2006Press releaseVeterinary